# NCT01726452 (NCT01726452)

> NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01726452
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Cancer Trials Ireland
- Conditions: Adenocarcinoma of the Oesophagus; Adenocarcinoma of the Oesophago-gastric Junction; Oesophageal Tumours; Junctional Tumours; Oesophageal Cancer
- Interventions: Epirubicin; Cisplatin / Oxaliplatin; 5 Flourouracil/ Capecitabine; (41.4 Gy/23 fractions); Paclitaxel; Carboplatin; Docetaxel; Oxaliplatin; Leucovorin; 5-Fluorouracil
- Enrollment: 377
- Primary outcome: Overall survival

## Commentary we found

- X threads: 65
- Podcasts: 12
- YouTube: 6

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct01726452

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01726452", "email": "<work email>"}; the inbox owner confirms by the emailed link.